Genesis Healthcare, Inc. GENNQ
—
0.00
0.00
NaN
as of 24 Sep
- Market cap
- —
- P/E
- 0.0×
Follow GENNQ
| Sep '21 | Jun '21 | Mar '21 | Dec '20 | Older periods | |
|---|---|---|---|---|---|
| (8.12%) | 2.87% | 11.08% | 5.25% |
+8 more TTM periods Free account |
|
| 2.45% | (0.83%) | (3.03%) | (1.35%) | ||
ROIC |
(25.67%) | (90.53%) | (297.91%) | (275.01%) | |
Return on Tangible Assets |
(7.90%) | 2.45% | 6.73% | 2.96% | |
Average Days of Receivables |
40.87 | 37.42 | 40.11 | 39.89 | |
Free Cash Flow per Share |
1.46 | (0.27) | 2.34 | 2.79 | |
Free Cash Flow |
176.38 | (32.49) | 266.57 | 312.32 | |
Capital Expenditures |
218.14 | 18.54 | 15.03 | (3.41) | |
Piotroski F-Score |
3.00 | 0.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(6.43%) | (7.42%) | 44.08% | 44.16% | |
Accounts Receivable Turnover |
8.13 | 8.65 | 7.72 | 7.86 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | (0.03) | (0.01) | (0.03) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
69.07% | 69.89% | 73.18% | 71.62% | |
Share Based Compensation of Revenue |
0.13% | 0.16% | 0.17% | 0.17% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.47) | 1.63 | (2.01) | (5.35) | |
Depreciation/Fixed assets |
0.14 | 0.14 | 0.13 | 0.11 | |
Capex/Depreciation |
1.70 | 0.14 | 0.12 | (0.03) | |
Revenue per Share |
28.17 | 30.08 | 32.57 | 34.92 | |
Operating CF per Share |
(0.35) | (0.43) | 2.21 | 2.82 | |
Capex per Share |
1.81 | 0.16 | 0.13 | (0.03) | |
Capex to Sales |
(0.06) | (0.01) | 0.00 | 0.00 | |
Net Profit Margin |
2.60% | (0.88%) | (3.36%) | (1.51%) |
Columns are period end dates